Literature DB >> 29705360

Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii.

Masoud Foroutan1, Fatemeh Ghaffarifar2, Zohreh Sharifi3, Abdolhosein Dalimi4, Majid Pirestani5.   

Abstract

Rhoptry proteins (ROPs) are involved in the different stages of Toxoplasma gondii (T. gondii) invasion and are also critical for survival within host cells. ROP8 is expressed in the early stages of infection and have a key role in the parasitophorous vacuole (PV) formation. In this paper, we have combined several bioinformatics online servers for immunogenicity prediction of ROP8 protein. In this study, several bioinformatics approaches were used to analyze the different aspects of ROP8 protein, including the physico-chemical properties, transmembrane domain, subcellular localization, secondary and tertiary structure, B and T-cell potential epitopes, and other important characteristics of this protein. The findings showed that ROP8 protein had 60 potential post-translational modification sites. Also, only one transmembrane domain was recognized for this protein. The secondary structure of ROP8 protein comprises 33.04% alpha-helix, 18.26% extended strand, and 48.70% random coil. Moreover, several potential B and T-cell epitopes were identified for ROP8. In addition, the obtained findings from antigenicity and allergenicity evaluation remarked that this protein is immunogenic and non-allergen. Based on the results of Ramachandran plot, 94.8%, 4.1%, and 1.1% of amino acid residues were incorporated in the favored, allowed, and outlier regions, respectively. This paper provides a foundation for further investigations, and laid a theoretical basis for the development of an appropriate vaccine against toxoplasmosis. More studies are needed experimentally using the ROP8 alone or in combination with other antigens in the future.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioinformatics analysis; ROP8; Toxoplasma gondii; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 29705360     DOI: 10.1016/j.meegid.2018.04.033

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  15 in total

1.  Seroepidemiological evaluation of Toxoplasma gondii immunity among the general population in southwest of Iran.

Authors:  Shahrzad Soltani; Masoud Foroutan; Hamed Afshari; Maryam Hezarian; Mehdi Sagha Kahvaz
Journal:  J Parasit Dis       Date:  2018-10-23

2.  Canine Adenovirus 1 Isolation Bioinformatics Analysis of the Fiber.

Authors:  Ben Wang; Minchun Wang; Hongling Zhang; Jinfeng Xu; Jinyu Hou; Yanzhu Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-13       Impact factor: 6.073

3.  In-depth computational analysis of calcium-dependent protein kinase 3 of Toxoplasma gondii provides promising targets for vaccination.

Authors:  Hamidreza Majidiani; Shahrzad Soltani; Ali Dalir Ghaffari; Mohamad Sabaghan; Ali Taghipour; Masoud Foroutan
Journal:  Clin Exp Vaccine Res       Date:  2020-07-31

4.  Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii.

Authors:  Ali Dalir Ghaffari; Abdolhossein Dalimi; Fatemeh Ghaffarifar; Majid Pirestani
Journal:  Clin Exp Vaccine Res       Date:  2020-07-31

Review 5.  A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran.

Authors:  Masoud Foroutan; Ali Rostami; Hamidreza Majidiani; Seyed Mohammad Riahi; Sasan Khazaei; Milad Badri; Elham Yousefi
Journal:  Epidemiol Health       Date:  2018-04-23

Review 6.  Recent progress in microneme-based vaccines development against Toxoplasma gondii.

Authors:  Masoud Foroutan; Leila Zaki; Fatemeh Ghaffarifar
Journal:  Clin Exp Vaccine Res       Date:  2018-07-31

7.  Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses.

Authors:  Su-Hwa Lee; Ki-Back Chu; Hae-Ji Kang; Fu-Shi Quan
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

8.  In silico analysis and expression of a new chimeric antigen as a vaccine candidate against cutaneous leishmaniasis.

Authors:  Leila Motamedpour; Abdolhossein Dalimi; Majid Pirestani; Fatemeh Ghaffarifar
Journal:  Iran J Basic Med Sci       Date:  2020-11       Impact factor: 2.699

9.  Bioinformatics analysis of calcium-dependent protein kinase 4 (CDPK4) as Toxoplasma gondii vaccine target.

Authors:  Masoud Foroutan; Shahrzad Soltani; Ali Taghipour; Ali Dalir Ghaffari; Hamidreza Majidiani; Mohamad Sabaghan
Journal:  BMC Res Notes       Date:  2021-02-06

10.  Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (CDPK7) Showed Potential Targets for Toxoplasma gondii Vaccine.

Authors:  Ali Taghipour; Sanaz Tavakoli; Mohamad Sabaghan; Masoud Foroutan; Hamidreza Majidiani; Shahrzad Soltani; Milad Badri; Ali Dalir Ghaffari; Sheyda Soltani
Journal:  J Parasitol Res       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.